Market Expansion Potential DORC's recent integration with ZEISS Group and the launch of its innovative EVA NEXUS platform position it strongly within the ophthalmic surgery technology sector, creating opportunities to sell advanced surgical systems and complementary accessories to hospitals and surgical centers seeking integrated ophthalmic solutions.
Product Adoption & Brand Trust With over 100,000 surgeries utilizing TissueBlue and a significant proportion of US retina surgeons preferring the product, DORC has established a strong foothold in retinal surgery markets, indicating potential for upselling new surgical stains, devices, and related consumables to existing and expanding customer bases.
Global Regulatory Milestones DORC's FDA and Health Canada approvals for its tissues and surgical products highlight compliance and reliability, making them attractive to international healthcare providers seeking certified ophthalmic solutions, thus opening avenues for targeted sales efforts in North America and other regulated markets.
Technological Innovation The company’s use of cutting-edge technology such as Power BI, Python, and integration with ZEISS suggests a focus on digital and intelligent surgical tools, presenting opportunities to introduce AI-enabled diagnostics, data analytics services, or enhanced surgical platforms to forward-thinking eye care facilities.
Funding & Growth Readiness Having secured substantial funding of $94 million and maintaining a revenue range of $10M to $25M, DORC demonstrates robust investment capacity for scaling product offerings, expanding sales teams, or entering new geographic markets, making it an attractive partner for strategic sales collaborations.
$100M$250M
$25M$50M
$10M$25M
$1B$10B
$10B
$500M$1B
$1B$10BDORC Dutch Ophthalmic Research Center (International) uses 8 technology products and services including Power BI, Fastly, SAP Maintenance, Repair, and Overhaul, and more. Explore DORC Dutch Ophthalmic Research Center (International)'s tech stack below.
| DORC Dutch Ophthalmic Research Center (International) Email Formats | Percentage |
| F.Last@dorc.eu | 89% |
| FLast@dorc.eu | 4% |
| First@dorc.eu | 1% |
| First.Last@dorc.eu | 1% |
| F_Last@dorc.eu | 1% |
| Last.First@dorc.eu | 1% |
| First-Last@dorc.eu | 1% |
| FiLast@dorc.eu | 1% |
| First_Last@dorc.eu | 1% |
| F.Last@dorcglobal.com | 100% |
Medical Equipment ManufacturingNetherlands501-1000 Employees
DORC, a ZEISS company, is one of the world’s leading suppliers of equipment, instruments and liquids for ophthalmic surgery. The company improves eye surgery globally and maximizes surgeon control by providing innovative quality approaches for eye disorders.
Company Overview
Media & News
Funding & FinancialsDORC Dutch Ophthalmic Research Center (International) has raised a total of $94M of funding over 2 rounds. Their latest funding round was raised on Jul 28, 2020 in the amount of $94M.
DORC Dutch Ophthalmic Research Center (International)'s revenue is estimated to be in the range of $10M$25M
Funding & FinancialsDORC Dutch Ophthalmic Research Center (International) has raised a total of $94M of funding over 2 rounds. Their latest funding round was raised on Jul 28, 2020 in the amount of $94M.
DORC Dutch Ophthalmic Research Center (International)'s revenue is estimated to be in the range of $10M$25M
1-888-653-2347 
support@leadiq.com